Literature DB >> 20869051

Nomogram for the decline in serum antimüllerian hormone: a population study of 9,601 infertility patients.

Scott M Nelson1, Martina C Messow, A Michael Wallace, Richard Fleming, Alex McConnachie.   

Abstract

OBJECTIVE: To define an optimal model for the decline in circulating antimüllerian hormone (AMH) with age and develop a validated age-related nomogram.
DESIGN: Cohort study with validation of linear, biphasic linear, differential, power, and quadratic equations undertaken in two additional cohorts.
SETTING: United Kingdom infertility clinics. PATIENT(S): Training cohort of 4,590 infertile women. Two separate validation cohorts; 4,588 infertile women, and 423 women with confirmed ovulation and normal pelvic ultrasound who have a male partner with severe oligospermia. INTERVENTION(S): Serum AMH measurement. MAIN OUTCOME MEASURE(S): Optimal fit and age-related AMH nomogram. RESULT(S): The linear model had the largest sum of absolute and squared residuals and provided a less adequate fit than the four nonlinear models. Of these, the R(2) ranged from 19.45% to 19.48% in the training dataset, from 21.30% to 21.36% in the validation dataset, and from 13.29% to 13.75% in the partners of oligospermic males. The parameters of the differential model were difficult to estimate, and the goodness-of-fit of the power model was slightly inferior to the quadratic model. CONCLUSION(S): Circulating AMH concentrations decline with increasing reproductive age in a manner optimally described by a quadratic equation. This validated age-related AMH nomogram will enable counseling of infertility patients regarding reproductive performance.
Copyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20869051     DOI: 10.1016/j.fertnstert.2010.08.022

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  35 in total

1.  Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener's).

Authors:  Megan E B Clowse; Susannah C Copland; Tsung-Cheng Hsieh; Shein-Chung Chow; Gary S Hoffman; Peter A Merkel; Robert F Spiera; John C Davis; W Joseph McCune; Steven R Ytterberg; E William St Clair; Nancy B Allen; Ulrich Specks; John H Stone
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-12       Impact factor: 4.794

2.  Treatment and preservation at the extremes of reproductive age: a case report outlining the ethical dilemmas.

Authors:  James D M Nicopoullos; Marie Wren; Hossam Abdalla
Journal:  J Assist Reprod Genet       Date:  2015-08-29       Impact factor: 3.412

3.  Anti-Mullerian hormone normogram in an Irish subfertile population.

Authors:  M N Naasan; C Harrity; L Pentony; E Mocanu
Journal:  Ir J Med Sci       Date:  2014-02-23       Impact factor: 1.568

4.  Obesity adversely affects serum anti-müllerian hormone (AMH) levels in Caucasian women.

Authors:  Vicky Moy; Sangita Jindal; Harry Lieman; Erkan Buyuk
Journal:  J Assist Reprod Genet       Date:  2015-07-21       Impact factor: 3.412

5.  AMH in women with diminished ovarian reserve: potential differences by FMR1 CGG repeat level.

Authors:  Lisa M Pastore; Timothy L McMurry; Christopher D Williams; Valerie L Baker; Steven L Young
Journal:  J Assist Reprod Genet       Date:  2014-06-18       Impact factor: 3.412

6.  Alcohol, cigarette smoking, and ovarian reserve in reproductive-age African-American women.

Authors:  Leah Hawkins Bressler; Lia A Bernardi; Peter John D De Chavez; Donna D Baird; Mercedes R Carnethon; Erica E Marsh
Journal:  Am J Obstet Gynecol       Date:  2016-07-11       Impact factor: 8.661

Review 7.  Anti-Müllerian hormone as a marker of ovarian reserve: What have we learned, and what should we know?

Authors:  Akira Iwase; Tomoko Nakamura; Satoko Osuka; Sachiko Takikawa; Maki Goto; Fumitaka Kikkawa
Journal:  Reprod Med Biol       Date:  2015-11-23

8.  Serum anti-müllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood.

Authors:  S Lie Fong; J A Visser; C K Welt; Y B de Rijke; M J C Eijkemans; F J Broekmans; E M Roes; W H M Peters; A C S Hokken-Koelega; B C J M Fauser; A P N Themmen; F H de Jong; I Schipper; J S E Laven
Journal:  J Clin Endocrinol Metab       Date:  2012-09-19       Impact factor: 5.958

9.  Attitudes towards potentially carrying the FMR1 premutation: before vs after testing of non-carrier females with diminished ovarian reserve.

Authors:  Lisa M Pastore; Maria Antero; Karen Ventura; J Kim Penberthy; Semara A Thomas; Logan B Karns
Journal:  J Genet Couns       Date:  2014-05-03       Impact factor: 2.537

10.  Novel correlates between antimüllerian hormone and menstrual cycle characteristics in African-American women (23-35 years-old).

Authors:  Erica E Marsh; Lia A Bernardi; Marissa L Steinberg; Peter J de Chavez; Jenny A Visser; Mercedes R Carnethon; Donna D Baird
Journal:  Fertil Steril       Date:  2016-04-23       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.